Dangerous Drugs in Texas: FDA Warns Fosamax May Cause Femur Fractures

Have you suffered a femur fracture or bone disease after taking Fosamax? You are not alone.

In September, two separate advisory panels for the Food and Drug Administration (FDA) recommended a revision of the labels on Fosamax and other drugs used to treat osteoporosis in women.

More than five million women in the United States take Fosamax in order to maintain bone strength and prevent bone fractures. But, when taken for extended periods, the drug has the potential to cause more damage than it prevents. The FDA became concerned about the long-term safety of Fosamax after receiving numerous reports about low-trauma femur fractures, bone infection, and bone death in patients taking Fosamax. Most of these patients had been taking the drug for more than five years, but some had taken it for as little as three years.

The advisory panel met to discuss the findings revealed in a 45 page report about the safety of Fosamax. The FDA report stated that there is “no significant advantage of continuing drug therapy beyond five years.” 

Although the FDA panel recommended new warnings, the FDA did not specify what the new safety warnings would say and whether they suggest limiting the use of the drug to a proposed five years. 

The revised labels are expected to come out in November.  They will be placed on Fosamax and other bisphosphonates, including Actonel and Boniva.

If you have suffered a femur fracture while taking Fosamax, you may have a Texas dangerous drugs claim. To learn if you have a case, contact a Dallas personal injury attorney at Van Wey Law, 800-489-5082.